Cardlytics shares surge 10.66% intraday after appointing former CFO David Evans to lead financial turnaround.

Cardlytics Inc. surged 10.66% intraday following the announcement that David Evans, a former executive who oversaw the company’s 2018 IPO, will return as Chief Financial Officer effective January 12, 2026. Evans, a seasoned leader with deep institutional knowledge, replaces outgoing CFO Alexis DeSieno, who will remain in an advisory role until March 6, 2026. The appointment signals a strategic move to stabilize the company’s turnaround, with Evans emphasizing his commitment to financial rigor and disciplined execution. Market participants viewed the return of an experienced leader as a positive catalyst amid ongoing operational challenges, including a 74% year-to-date stock decline and recent Q3 earnings that showed a narrower-than-expected loss but below-forecast revenue. The news reinforced investor confidence in leadership continuity and long-term value creation.